What is EW's current stock price?

As of now, EW is trading at $83.48, with a daily change of +0.96%.

What are the risks associated with EW stock?

EW Key risk is its Moderate Risk Level, .

What is EW next earnings date?

EW next earnings report is scheduled for Oct 30, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

EW Stock Analysis & IQ Rating | Edwards Lifesciences

EW

Edwards Lifesciences

$83.48

+$0.79 | +0.96%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

Latest Comments

Market Warriors Bounce! $NUAI $FDMT $EW flip the script from red to green early dip, big comeback, traders celebrating the turnaround!

October 27, 2025 01:32 PM

52W High

$ 84.66

MKT CAP

$ 49.01B

52W Low

$ 64.89

VOL

$ 6.50M

P/E Ratio

11.99

AVG VOL

$ 5.01M

RSI

74.00

TREND

Sideways

alert Latest Updates

TopRated 12:55 PM

received a significant boost from Raymond James, upgrading Amerant Bancorp from Market Perform to Outperform with a 46.24% upside forecast.

saw HSBC upgrade ...

EW Stock IQ

Login to see Edwards Lifesciences (EW) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

EW Target Price

Login to display

Strengths

EW Rewards

Upgraded on attractively valued

EW Rewards

Earnings are forecast to grow

EW Rewards

Expands stock buyback program

Chart

$76.65 (+8.91%)

$78.61 (+6.20%)

$75.82 (+10.10%)

$65.81 (+26.85%)

1year

6month

3month

1month

EW Risk Level

EW has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

LOW

HIGH

EW Analysts Opinion

EW overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

EW Analysts Opinion

EW Analysts opinion is negative and it remained unchanged from the past 3 months

EW Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

88%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

83%

100%

EW Street Opinion

EW Street view is extremely bullish and have negative views on the near-term outlook

EW Performance Sentiment

Sentiments overview associated with EW events and the stock performance.

88%

6%

Positive

Negative

14 out of 16
events present

1 out of 16
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$76.11

Resistance
Price

$73.75

Current Price Range

$77.48

Show methods +

EW Earnings

The TTM reflects 12-month period, providing review of EW financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

5,685

5,440

5,010

+6.52%

Cost of Revenue

1,201

1,118

978

+10.82%

Gross Profit

4,484

4,322

4,032

+5.46%

Operating Exp

2,896

2,842

2,545

+6.67%

Operating Inc

1,588

1,480

1,486

+3.38%

Net Interest Inc

142

101

50

+68.52%

Interest Exp

-

20

18

-

Interest Inc

162

120

67

+55.50%

Other Inc Exp

-104

-33

-163

-

EPS Growth

6.97

6.98

2.31

+73.70%

EW Financial Health

The company financial health has moderately improved over the past year

Financial Score

3.85

Next Earnings Date: Oct 30, 2025

EW Latest Analysis +

Wolfe Research Upgrades Edwards Lifesciences (EW). Fintel reports that on October 29 2025 Wolfe Research upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Underperform to Peer Perform. Analyst Price Forecast Suggests 8.55% Upside

Today

$83.48 | +0.96%

Potential

Rating

This Edwards Lifesciences Analyst Turns ish. Here Are Top 4 Upgrades For Wednesday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations please see our analyst ratings page.HC Wainwright &. Co. analyst Swayampakula Ramakanth upgraded IPHA) from Neutral to Buy and announced a $5 price target. Innate Pharma shares closed at $2.09 on Tuesday. See how other analysts view this stock.Baird

Wed Oct 29, 2025

$82.69 | +0.61%

Potential

Rating

Edwards Lifesciences nabs upgrades from Jefferies Wolfe.

Wed Oct 29, 2025

$82.69 | +0.61%

Rating

Exploring Analyst Estimates for Edwards Lifesciences (EW) Q3 Earnings Beyond Revenue and EPS. Besides Wall Streets top-and-bottom-line estimates for Edwards Lifesciences (EW) review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

Tue Oct 28, 2025

$82.19 | +1.70%

Earnings

Edwards Lifesciences jumps on data for SAPIEN M3 EVOQUE valve replacements.

Mon Oct 27, 2025

$80.82 | +6.20%

Momentum

Piper Sandler Maintains Overweight on Edwards Lifesciences (EW) Ahead of PARTNER 3 7-Year Results.

Tue Oct 21, 2025

$76.02 | +0.97%

Rating

ish Two Hundred Day Moving Average Cross - EW. In trading on Monday shares of Edwards Lifesciences Corp (Symbol: EW) crossed above their 200 day moving average of $74.84 changing hands as high as $75.57 per share. Edwards Lifesciences Corp shares are currently trading up about 0.6% on the day. The chart below shows the o

Mon Oct 20, 2025

$75.34 | +0.88%

Momentum

Technical

Robust TAVR Growth to Drive Edwards Lifesciences Q3 Earnings. Strong TAVR demand and expanding valve therapies are set to power EWs Q3 results despite lower EPS estimates.

Fri Oct 17, 2025

$74.64 | +2.74%

Activity

Oversold Conditions For Edwards Lifesciences (EW). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Mon Oct 13, 2025

$72.95 | -0.01%

Technical

Heres How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today. Edwards Lifesciences (NYSE:) has outperformed the market over the past 15 years by 1.34% on an annualized basis producing an average annual return of 13.44%. Currently Edwards Lifesciences has a market capitalization of $43.41 billion.

Fri Oct 10, 2025

$73.97 | -1.64%

Activity

FAQ About EW Stock Insights

What is EW current stock price?

What are EW stock strengths?

What risks are associated with EW stock?

When is EW next earnings report?

What is EW market cap and volume?

What is EW's current Stock IQ?

Should I buy EW stock right now?

Is EW a Strong Buy right now?

What does a 'Strong Buy' rating mean for EW?

What does a 'Strong Sell' rating mean for EW?

What factors influence EW's Stock IQ?

Explore our EW Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored EW Stock Strategies
Effective Risk Management

FIND US ON

Receive our EW Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

EW

Edwards Lifesciences

Current Price

$83.48

+$0.79 | +0.96%

52W High

$ 84.66

MKT CAP

$ 49.01B

52W Low

$ 64.89

VOL

$ 6.50M

P/E Ratio

11.99

AVG VOL

$ 5.01M

RSI

74.00

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

EW Rewards

Upgraded on attractively valued

EW Rewards

Earnings are forecast to grow

EW Rewards

Expands stock buyback program

Latest Comments

Market Warriors Bounce! $NUAI $FDMT $EW flip the script from red to green early dip, big comeback, traders celebrating the turnaround!

October 27, 2025 01:32 PM

EW Stock IQ

Login to unlock Edwards Lifesciences (EW) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$76.65 (+8.91%)

$78.61 (+6.20%)

$75.82 (+10.10%)

$65.81 (+26.85%)

1year

6month

3month

1month

EW Analysts Opinion

EW Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

EW Analysts Opinion

EW Analysts opinion is negative and it remained unchanged from the past 3 months

EW Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

88%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

83%

100%

EW Street Opinion

EW Street view is extremely bullish and have negative views on the near-term outlook

EW Risk Level

EW has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

LOW

HIGH

EW Performance Sentiment

Sentiments overview associated with EW events and the stock performance.

88%

6%

Positive

Negative

14 out of 16
events present

1 out of 16
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$76.11

Resistance
Price

$73.75

Current Price Range

$77.48

Show methods +

EW Earnings

The TTM data reflects the most recent 12-month period, providing overview of EW financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

5,685

5,440

5,010

+6.52%

Cost of Revenue

1,201

1,118

978

+10.82%

Gross Profit

4,484

4,322

4,032

+5.46%

Operating Exp

2,896

2,842

2,545

+6.67%

Operating Inc

1,588

1,480

1,486

+3.38%

Net Interest Inc

142

101

50

+68.52%

Interest Exp

-

20

18

-

Interest Inc

162

120

67

+55.50%

Other Inc Exp

-104

-33

-163

-

EPS Growth

6.97

6.98

2.31

+73.70%

EW Financial Health

The company financial health has moderately improved over the past year

Financial Score

3.85

Next Earnings Date: Oct 30, 2025

EW Latest Analysis

TopRated 12:55 PM

received a significant boost from Raymond James, upgrading Amerant Bancorp from Market Perform to Outperform with a 46.24% upside forecast.

saw HSBC upgrade ...

Discover EW Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of EW. We're here to help you make informed investment decisions today.

FIND US ON

Receive our EW Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

EW Stock trends

EW Stock performance

EW Stock analysis

EW investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing EW

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing EW

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

EW Stock Analysis & IQ Rating | Edwards Lifesciences

Latest Comments

EW Stock IQ

EW Target Price

EW Risk Level

EW Analysts Opinion

EW Street Consensus

EW Performance Sentiment

Technical Price Levels

EW Financial Health

Explore our EW Stock insights

Receive our EW Daily Alerts

Latest Comments

EW Stock IQ

EW Street Consensus

EW Risk Level

Technical Price Levels

Discover EW Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of EW. We're here to help you make informed investment decisions today.

Receive our EW Daily Alerts

EW Runner Alarm